InsidersTradesSigma
Track the Chordia Therapeutics 株式会社 share price and the full directors' dealings record of the company, a listed issuer based in Japan. Shares trade on JP JP, under the oversight of EDINET (Japan FSA). The latest transaction was reported on 10 March 2026 (Holding update). Among the most active insiders: Kyoto University Innovation Capital Co.,Ltd.. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
7 of 7 declarations
Chordia Therapeutics is a Japanese company focused on developing innovative therapies. It operates on the Tokyo Stock Exchange under the symbol XTKS.